The clinical trial of the comparison of Transdiagnostic Therapy with cognitive- behavior therapy on patients with depression and anxiety disorders
Not Applicable
Completed
- Conditions
- anxiety disorders and depression.generalized anxiety disorder, moderate depressive episodef32.1, f41
- Registration Number
- IRCT2014010516085N1
- Lead Sponsor
- Deputy of Research of Medicine School of Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
age 18 or older; be fluent in Persian; be able to attend all treatment sessions and assessments; provide informed consent
Exclusion criteria: have evidence of dementia or other neuro-cognitive conditions that impair ability; have clinical conditions that require immediate treatment; suicidality; substance use disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety. Timepoint: at the end of treatment. Method of measurement: by questionnaire.
- Secondary Outcome Measures
Name Time Method Depression. Timepoint: at the end of treatment. Method of measurement: by questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neural mechanisms underlie transdiagnostic therapy's impact on emotion regulation in depression and anxiety disorders compared to CBT?
How does transdiagnostic therapy compare to CBT in improving emotion regulation strategies for generalized anxiety disorder and moderate depressive episodes?
What biomarkers correlate with treatment outcomes in IRCT2014010516085N1 comparing transdiagnostic therapy and CBT for depression and anxiety disorders?
What are the safety profiles and adverse events associated with transdiagnostic therapy versus CBT in treating F32.1 and F41 disorders?
How do transdiagnostic therapy and CBT compare when combined with SSRIs for generalized anxiety disorder and depression?